Satoe Fujiwara 藤原聡枝

… Alternative Names

Fujiwara Satoe 藤原聡枝

Less

Researcher Number	90707960
Other IDs
Affiliation (Current)	2025: 大阪医科薬科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2021 – 2023: 大阪医科薬科大学, 医学部, 講師 2017 – 2020: 大阪医科大学, 医学部, 講師 2014 – 2016: 大阪医科大学, 医学部, 助教
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Obstetrics and gynecology Except Principal Investigator Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related
Keywords	Principal Investigator 卵巣癌 / T細胞 / 免疫応答 / 腫瘍免疫 / エリブリン / 難治性卵巣癌 / EMT現象 / EMT / GPR30 Except Principal Investigator 卵巣癌 … More / 子宮頸癌 / BNCT / マイクロRNA / 肥満 / miRNA / 硼素中性子捕捉療法 / オルガノイド / 脂肪細胞 / 子宮頚癌 / 子宮体がん / 癌関連繊維芽細胞 / EMT / エキソソーム / 癌免疫 / 直接腫瘍移植モデル / 臨床腫瘍検体直接移植モデル / 腫瘍免疫 / 細胞外小胞 / 同時化学放射線療法 / LAT-1 / LAT1 / ホウ素中性子補足療法 / 再発 / ホウ素 / 卵巣がん / 癌免疫治療 / 放射線治療 / 硼素内包高分子ミセル / 硼素化合物 / 子宮頸がん / Endothelinー2 / 上皮間葉形態転換 / ニッチ / 上皮・間葉形態転換 / ドラッグデリバリーシステム / 高分子ミセル / 癌幹細胞 / がん微小環境 / アディポカイン / がん / がん関連繊維芽細胞 / FABP4 / 腫瘍随伴マクロファージ / 癌 / エクソソーム / exosome / 子宮体癌 / 癌関連線維芽細胞 / mi RNA / CD24 / 浸潤・転移 / 抗がん剤 / 卵巣保護 / AMH / テストステロン / 顆粒膜細胞 / アルキル化剤 / 卵巣毒性 / microRNA / 癌微小環境 Less

卵巣癌再発・転移に対して硼素中性子捕捉療法の有用性の検討
- Principal Investigator
  
  恒遠啓示
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
硼素中性子捕捉療法とLAT1を介した化学療法を併用する子宮頸癌の新たな治療戦略
- Principal Investigator
  
  寺田信一
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
癌特異的EVs内のmiRNAをターゲットとした腫瘍免疫システムの機序解明
- Principal Investigator
  
  田中智人
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Elucidation of the mechanism of cancer invasion and metastasis by adipocytes using ovarian cancer organoids
- Principal Investigator
  
  HIROSHI SASAKI
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Establishment of personalized medicine for refractory ovarian cancer using 3D organoid culture
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Research on treatment of cervical cancer by combined cancer immunotherapy
- Principal Investigator
  
  Hayashi Masami
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical and Pharmaceutical University
Target therapy of ovarian cancer including immunotherapy via EribulinPrincipal Investigator
- Principal Investigator
  
  FUJIWARA SATOE
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Osaka Medical College
Research for cancer microenvironment via FABP4 in endometrial cnacer
- Principal Investigator
  
  Sasaki Hiroshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT
- Principal Investigator
  
  Ohmichi Masahide
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Treatment strategy of boron neutron capture therapy in cervical cancer
- Principal Investigator
  
  Tsunetoh Satoshi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- Principal Investigator
  
  Terai Yoshito
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Kobe University
  Osaka Medical College
activation regulatory mechanism of cancer fibroblast by obesity
- Principal Investigator
  
  Takai Masaaki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
A novel approach for cervical cancer using exosome
- Principal Investigator
  
  Hayashi Masami
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity
- Principal Investigator
  
  Tanabe Akiko
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancerPrincipal Investigator
- Principal Investigator
  
  Fujiwara Satoe
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College
The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.
- Principal Investigator
  
  SASAKI HIROSHI
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka Medical College

All 2022 2020 2019 2018 2017

All Journal Article Presentation

[Journal Article] Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer2020
- Author(s)
  Maeda K, Sasaki H, Ueda S, Miyamoto S, Terada S, Konishi H, Kogata Y, Ashihara K, Fujiwara S, Tanaka Y, Tanaka T, Hayashi M, Ito Y, Kondo Y, Ochiya T, Ohmichi M
- Journal Title
  
  J Ovarian Res.
  
  Volume: 13 Issue: 1 Pages: 47-47
- DOI
  10.1186/s13048-020-00648-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-16K10482, KAKENHI-PROJECT-17K11303
[Journal Article] Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer2020
- Author(s)
  Ashihara K, Terai Y, Tanaka T, Tanaka Y, Fujiwara S, Maeda K, Tunetoh S, Sasaki H, Hayashi M, Ohmichi M.
- Journal Title
  
  Oncol Lett.
  
  Volume: 19 Pages: 1872-1880
- DOI
  10.3892/ol.2020.11279
- NAID
  120006873100
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09838, KAKENHI-PROJECT-17K11303, KAKENHI-PROJECT-17K11304
[Journal Article] CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.2017
- Author(s)
  Nakamura K, Terai Y, Tanabe A, Ono YJ, Hayashi M, Maeda K, Fujiwara S, Ashihara K, Nakamura M, Tanaka Y, Tanaka T, Tsunetoh S, Sasaki H, Ohmichi M.
- Journal Title
  
  Oncol Rep
  
  Volume: - Issue: 6 Pages: 3189-3200
- DOI
  10.3892/or.2017.5583
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541, KAKENHI-PROJECT-16K11162, KAKENHI-PROJECT-16K11165, KAKENHI-PROJECT-17K11304
[Journal Article] The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer.2017
- Author(s)
  anaka T, Terai Y, Ashihara K, Fujiwara S, Tanaka Y, Sasaki H, Tsunetoh S, Ohmichi M
- Journal Title
  
  PLoS One
  
  Volume: 12 Issue: 5 Pages: e0177019-e0177019
- DOI
  10.1371/journal.pone.0177019
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26462541
[Presentation] 子宮体がんにおける個別化治療にむけたPDXモデルの検討2022
- Author(s)
  上田尚子、西江瑠璃、橋田宗祐、宮本瞬輔、寺田信一、古形祐平、藤原聡枝、田中良道、田中智人、大道正英
- Organizer
  第64回日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-22K09655
[Presentation] 進行婦人科癌患者における腹水・胸水を用いた患者由来がんモデルの作製と検証2022
- Author(s)
  西江瑠璃、田中智人、村上　暉、上田尚子、橋田宗祐、宮本瞬輔、寺田信一、古形祐平、藤原聡枝、田中良道、恒遠啓示、佐々木浩、山田隆司、大道正英
- Organizer
  第64回日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-22K09655
[Presentation] 当科におけるがん婦人科遺伝パネル検査の現状2022
- Author(s)
  寺田信一、田中智人、村上　暉、西江瑠璃、土橋裕允、田路明彦、上田尚子、宮本瞬輔、橋田宗祐、古形祐平、藤原聡枝、田中良道、恒遠啓示、佐々木浩、大道正英
- Organizer
  第147回近畿産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-22K09655
[Presentation] 婦人科癌肉腫におけるPDX(Patient-Derived Xenograft)モデル2022
- Author(s)
  宮本瞬輔、村上　暉、西江瑠璃、上田尚子、橋田宗祐、寺田信一、古形祐平、藤原聡枝、田中良道、田中智人、恒遠啓示、山田隆司、大道正英
- Organizer
  第64回日本婦人科腫瘍学会学術講演会
- Data Source
  KAKENHI-PROJECT-22K09655
[Presentation] New approaches using exosome for cervical cancer treatment.2019
- Author(s)
  Hiromi Konishi, Masami Hayashi, Shinichi Terada, Kana Kokunai, Natsuho Nakamura, Sayaka Taga, Satoe Fujiwara, Hiroshi Sasaki, Yoshito Terai, Masahide Ohmichi
- Organizer
  第71回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-19K09791
[Presentation] GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer2018
- Author(s)
  藤原聡枝　田中良道　田中智人　恒遠啓示　佐々木浩　寺井義人　大道正英
- Organizer
  International Gynecologic Cancer Society 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K10738
[Presentation] 難治性卵巣癌モデルマウスに対するCD24を標的とした高分子ミセルを用いた新規治療2017
- Author(s)
  芦原敬允, 寺井義人, 土橋裕允, 藤原聡枝, 田中良道, 田中智人, 恒遠啓示, 佐々木浩, 林正美, 大道正英
- Organizer
  第69回日本産科婦人科学会学術集会
- Data Source
  KAKENHI-PROJECT-17K11304

1. Ohmichi Masahide (10283764)

# of Collaborated Projects: 16 results

# of Collaborated Products: 11 results
2. Hayashi Masami (00551748)

# of Collaborated Projects: 15 results

# of Collaborated Products: 4 results
3. 田中良道 (10625502)

# of Collaborated Projects: 15 results

# of Collaborated Products: 10 results
4. SASAKI HIROSHI (80432491)

# of Collaborated Projects: 14 results

# of Collaborated Products: 7 results
5. Tsunetoh Satoshi (70388255)

# of Collaborated Projects: 14 results

# of Collaborated Products: 7 results
6. Terai Yoshito (90278531)

# of Collaborated Projects: 11 results

# of Collaborated Products: 6 results
7. Tanabe Akiko (70454543)

# of Collaborated Projects: 8 results

# of Collaborated Products: 1 results
8. 田中智人 (90411363)

# of Collaborated Projects: 8 results

# of Collaborated Products: 7 results
9. 兪史夏 (80625674)

# of Collaborated Projects: 6 results

# of Collaborated Products: 0 results
10. 金村昌徳 (40298782)

# of Collaborated Projects: 3 results

# of Collaborated Products: 0 results
11. 古形祐平 (80829953)

# of Collaborated Projects: 2 results

# of Collaborated Products: 1 results
12. 寺田信一 (60861242)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
13. Takai Masaaki (90770933)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 劉昌恵 (00849581)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 上田尚子 (70920148)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results

Satoe Fujiwara 藤原 聡枝

Fujiwara Satoe 藤原 聡枝

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Target therapy of ovarian cancer including immunotherapy via EribulinPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Satoe Fujiwara 藤原聡枝

Fujiwara Satoe 藤原聡枝